. Effects of crocetin on pulmonary gas exchange in foxhounds during hypoxic exercise. J Appl Physiol 89: 235-241, 2000.-The carotenoid compound crocetin has been hypothesized to enhance the diffusion of O 2 through plasma, and observations in the rat and rabbit have revealed improvement in arterial PO 2 when crocetin is given. To determine whether crocetin enhances diffusion of O 2 between alveolar gas and the red blood cell in the pulmonary capillary in vivo, five foxhounds, two previously subjected to sham and three to actual lobectomy or pneumonectomy, were studied while breathing 14% O 2 at rest and during moderate and heavy exercise before and within 10 min after injection of a single dose of crocetin as the trans isomer of sodium crocetinate (TSC) at 100 g/kg iv. This dose is equivalent to that used in previous studies and would yield an initial plasma concentration of 0.7-1.0 g/ml. Ventilation-perfusion inequality and pulmonary diffusion limitation were assessed by the multiple inert gas elimination technique in concert with conventional measurements of arterial and mixed venous O 2 and CO 2 . TSC had no effect on ventilation, cardiac output, O 2 consumption, arterial PO 2 /saturation, or pulmonary O 2 diffusing capacity. There were minor reductions in ventilation-perfusion mismatching (logarithm of the standard deviation of perfusion fell from 0.48 to 0.43, P ϭ 0.001) and in CO 2 output and respiratory exchange ratio (P ϭ 0.05), which may have been due to TSC or to persisting effects of the first exercise bout. Spectrophotometry revealed that TSC disappeared from plasma with a half time of ϳ10 min. We conclude that, in this model of extensive pulmonary O 2 diffusion limitation, TSC as given has no effect on O 2 exchange or transport. Whether the original hypothesis is invalid, the dose of TSC was too low, or plasma diffusion of O 2 is not rate limiting without TSC cannot be discerned from the present study. diffusing capacity; ventilation-perfusion inequality; multiple inert gas elimination technique
A SERIES OF RECENT PUBLICATIONS from the laboratory of Gainer et al. (2, 6, 8, 10, 16) have provided intriguing evidence that the carotenoid compound crocetin enhances systemic O 2 transport and tissue oxygenation in a variety of circumstances. In the papain-treated rat model of emphysema (2) , arterial PO 2 was restored to normal after 4 wk of daily administration of crocetin at 0.5 mg ip. Similar data were obtained in normal anesthetized rabbits (10) . In hemorrhaged rats, cerebral tissue PO 2 measured by microelectrodes was 7.6 Torr after a single intravenous bolus of crocetin (16) compared with 3.2 Torr in untreated but hemorrhaged rats. In other hemorrhaged rats, crocetin injected into a carotid artery resulted in 100% survival, whereas control animals suffered 50% mortality (6, 8) . It was proposed that the physiological basis of these remarkable effects is enhanced diffusion of O 2 in plasma and in vitro evidence for such an effect was presented (6) , although the physicochemical basis remains obscure (5) .
Although these results in intact animals appear to show overall enhancement of O 2 supply to tissues, the physiological mechanism(s) remains to be determined. The experimental approaches in these studies lack the discrimination to discern between effects of crocetin on many of the steps in the O 2 transport chain from the environment to the mitochondria.
Because the proposed mechanism is enhanced diffusion of O 2 through plasma, it would make sense to examine the effects of crocetin in a diffusion-limited setting. Thus, if diffusive equilibrium between alveolar gas and pulmonary end-capillary blood exists, enhancing plasma diffusion of O 2 would not be expected to improve O 2 transport. Because diffusion limitation is not thought to play a role in the hypoxemia of emphysema, at least in humans (1, 14, 15, 19) , it is difficult to understand the basis of improved arterial PO 2 in the emphysematous rat (2) . Perhaps crocetin stimulated ventilation or altered ventilation-perfusion (V A/Q ) relationships in some manner. Similarly, in the hemorrhaged rats (16) , tissue perfusion or its distribution, rather than diffusion, may have been improved to explain the higher tissue PO 2 values.
Because of these uncertainties, we designed a study to directly test the hypothesis that crocetin improves arterial PO 2 through enhanced diffusion. We used doses similar, per kilogram of body weight, to those reported in the studies of Gainer et al. (8, 10, 16) . We chose the exercising foxhound in which to study gas exchange, because, in hypoxia, this species becomes greatly diffusion limited in its pulmonary gas exchange (11) . This is seen even in the intact foxhound but is more pronounced after recovery from partial lung resection. We used the multiple inert gas elimination technique (MIGET) (4, 20) to distinguish among the various causes of hypoxemia: 1) diffusion limitation, 2) V A/Q inequality, 3) shunt, and 4) hypoxemia from relative hypoventilation during exercise.
In summary, we were unable to show any effect of crocetin on arterial oxygenation, despite conditions of considerable alveolar-capillary O 2 diffusion limitation.
METHODS
Five foxhounds were used in the study, which had been approved by the University of Texas Southwestern Medical Center Animal Use Committee. Two of the animals had previously undergone bilateral lobectomy, one had undergone right pneumonectomy, and the other two were shamoperated controls with normal lungs. All were males, and their average weight was 23.5 kg.
Outline of the protocol. All studies were carried out with the dogs breathing 14% O 2 to magnify O 2 diffusion limitation of pulmonary gas exchange. Each dog was studied twice, with 1 h separating the two experiments. After catheterization (see below), data were collected in duplicate 1) at rest, 2) during moderate exercise, and 3) during heavy exercise. For all dogs, moderate exercise consisted of running at 6 miles/h on a horizontal treadmill. Heavy exercise involved running at 8 miles/h at inclines of 0-15% depending on the capabilities of each dog. The target load for heavy exercise was to attain the highest power output sustainable for the 5 min required to reach a steady state and then to complete sampling procedures. The two executions of this protocol were purposely identical to each other in speed, incline, and duration. The first run was the control experiment, in which only the phosphate buffer used to dissolve crocetin was given; the second run was commenced Ͻ5 min after the intravenous injection of 100 g/kg of crocetin given as the trans isomer of sodium crocetinate (TSC). Given a blood volume of 70-100 ml/kg, initial blood concentration would be 0.7-1.0 g/ml. In three of the dogs, the disappearance of TSC from plasma was followed spectrophotometrically for ϳ20-30 min with use of blood samples collected during the actual experiment. TSC was kindly supplied by Dr. John Gainer (Dept. of Chemical Engineering, University of Virginia).
Dog preparation. Three catheters were placed percutaneously in each dog (with use of local anesthesia and sterile technique) immediately before the study: a carotid artery catheter was placed into a previously elevated carotid artery, a jugular venous catheter was used to infuse the saline solution of the six inert gases used in the MIGET, and a thermodilution Swan-Ganz catheter was advanced into the pulmonary artery. From these catheters, systemic and pulmonary arterial pressures were continuously monitored and blood samples were withdrawn at designated times. In addition, the pulmonary arterial catheter recorded central body temperature. All catheters were secured by a collar and led out around the back of the neck to be connected to pressure transducers and sampling ports. Vascular pressures were referenced to a fluid-filled catheter sutured to the dog's midchest along the anteroposterior diameter.
Each dog was fitted with its own previously constructed tight-fitting face mask that was connected to a Hans Rudolph nonrebreathing valve. This valve was connected on the inspired side to a meteorological balloon (200 liters) kept full with 14% O 2 . The expired side was connected to heated, metal mixing boxes, so that mixed expired inert and respiratory gas concentrations could be sampled as desired.
Measurements. Ventilation was measured on the expiratory side by a heated, calibrated Hans Rudolph pneumotachograph (model 4813) and reported as BTPS. Mixed expired O 2 and CO 2 concentrations were measured continuously by a mass spectrometer (model MGA 1100, Perkin-Elmer), and O 2 consumption (V O 2 ) and CO 2 production (V CO 2 ) were calculated, averaged, and displayed every 10 breaths in real time to monitor attainment of a steady-state V O 2 during exercise.
Heparinized 3-ml arterial and pulmonary arterial blood samples were collected anaerobically during steady-state conditions, placed on ice, and analyzed on Radiometer electrodes (ABL 500) and with a hemoximeter (model OSM3) at 37°C. Values for PO 2 half-saturation pressure of Hb (P 50 ) was determined as the value that minimized the sum of squares of the differences between measured O 2 saturation and that calculated from measured PO 2 , PCO 2 , and pH with use of the Kelman algorithms (12, 13) over all 12 (6 arterial and 6 venous) samples before administration of TSC. The same process was used to separately calculate P 50 from the 12 blood samples taken during the second exercise run after crocetin administration.
The alveolar gas equation was used to compute the alveolar-arterial PO 2 difference (A-aPO 2 ) from the temperaturecorrected arterial PO 2 and PCO 2 values and the measured respiratory exchange ratio.
The MIGET was utilized in the manner described previously (4, 11) . Duplicate 20-ml mixed expired samples were collected at the same time as single 6-ml arterial blood samples at each of the six times of data collection (rest and moderate and heavy exercise) before and after administration of TSC. Because of time limitations, which prevented blood sampling from the Swan-Ganz catheter, measured values of ventilation and cardiac output were used to compute pulmonary arterial inert gas levels by mass balance from the expired and arterial levels. From the resulting retention and excretion ratios of the six gases (SF 6 , ethane, cyclopropane, enflurane, ether, and acetone), moments of the V A/Q distribution were computed in the standard manner. We used the second moment about the mean on a logarithmic scale as the index of V A/Q dispersion. In addition, arterial PO 2 was predicted from the MIGET-derived V A/Q distribution and compared with the measured arterial PO 2 . When the former exceeded the latter, indicating causes of hypoxemia over and above 1) V A/Q inequality, 2) shunt, and 3) inadequate ventilation, a whole lung diffusing capacity (DL O2 ) was calculated from the algorithm of Hammond and Hempleman (9) . Especially in hypoxia, when the measured arterial PO 2 is less than that predicted via MIGET, alveolar-capillary diffusion limitation is the generally accepted explanation, although postpulmonary shunting could in theory also account for such a difference (18) . The calculation of DL O 2 explicitly assumes that, regionally, diffusing capacity is distributed in proportion to local blood flow. Accordingly, this estimate of DL O 2 is the lowest whole lung value that will account for the difference between measured and predicted values of arterial PO 2 . In the context of the present study, DL O 2 is a lumped parameter that per se cannot ascribe specific resistance to diffusion to any component of the O 2 transport pathway between alveolar gas and Hb within the red blood cell. However, comparison of values before and after TSC will reveal any change in overall conductance for O 2 across the lung independent of V A/Q inequality, shunt, and ventilation.
Spectrophotometric analysis of TSC in plasma. Remaining arterial blood samples used for MIGET analysis or blood-gas measurement were centrifuged at 4,200 rpm for 10 min, and the plasma was removed and protected from light. Diluted TSC and plasma before TSC injection were also obtained, and all samples were scanned in a spectrophotometer (model DU-70, Beckman). Absorbance at 540 nm (where TSC shows no activity) and absorbance at 450 nm (where TSC shows peak activity) were measured. The value at 450 nm was corrected for the (non-TSC) signal appearing at 540 nm to yield a value reflecting the contribution of TSC to the 450-nm signal. From semilogarithmic plots of absorbance as a function of time after TSC injection, plasma half time was computed in three dogs.
Statistical analysis. Repeated-measures ANOVA was used to assess the effects of TSC and exercise on the principal outcome variables pertaining to gas exchange, with PՅ0.05 set as the discriminating level of significance. 2 . Figure 1 shows the relationships between V O 2 and V CO 2 before and after TSC at rest and during moderate and heavy exercise. V O 2 was clearly unaffected by TSC, with values at each metabolic rate on the identity line. However, V CO 2 appeared systematically reduced, albeit to a minor degree. Although this reduction failed to reach significance, the ratio of V CO 2 to V O 2 (i.e., the respiratory exchange ratio) was systematically lower after TSC by 0.1 unit (P ϭ 0.05). Figure 2 shows ventilation, tidal volume, cardiac output, and heart rate, each as a function of V O 2 , and demonstrates no effects of TSC. Neither systemic-nor pulmonary artery-cardiac output relationships were affected by TSC (not shown). Figure 3 shows arterial PO 2 (measured and predicted), arterial PCO 2 (measured and predicted), and AaPO 2 (measured and predicted) before and after TSC. These relationships are plotted against V O 2 and show that 1) TSC had no effect on measured or predicted Fig. 1 . O 2 uptake (V O 2 ) and CO 2 output (V CO 2 ) measured from mixed expired gas before and after 100 g/kg iv bolus injection of the trans isomer of sodium crocetinate (TSC). Data are shown for rest and moderate and heavy exercise, all at inspiratory O 2 fraction of 0.14. V O 2 was not affected by TSC, but V CO 2 was slightly reduced. values of arterial PO 2 , 2) predicted PO 2 was considerably higher than measured PO 2 during moderate and heavy exercise, 3) TSC was associated with an arterial PCO 2 that was lower by 2-3 Torr (P ϭ 0.01), 4) there was no difference between measured and predicted arterial PCO 2 before or after TSC, 5) TSC had no effect on the measured A-aPO 2 but was associated with a slightly reduced predicted value for A-aPO 2 of 1 Torr (P ϭ 0.001), and 6) during exercise, but not at rest, the measured A-aPO 2 greatly exceeded the predicted values (18 vs. 5 Torr, P Ͻ 0.001), indicating that the great majority of the A-aPO 2 is due to diffusion limitation. Figure 3 also shows that measured arterial O 2 saturation was not affected by TSC but fell significantly with exercise. Figure 4 shows a small but systematic reduction in V A/Q inequality, as depicted by log SD Q , the second moment of the perfusion distribution about its mean, after treatment with TSC. This explains the small reduction in predicted A-aPO 2 of 1 Torr shown in Fig. 3 . Also shown in Fig. 4 is DL O 2 ; TSC had no significant effect on this variable. Figure 5 shows the spectrophotometric measurements of plasma absorbance in one dog, indicating TSC disappearance from the blood with a first-order process. The half time was similar among all three dogs so examined (10.9, 11.4, and 9.2 min) and was therefore ϳ10 min. P 50 was 28.0 Torr before TSC and 28.0 Torr after TSC, with no significant effect of TSC.
RESULTS
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DISCUSSION
Summary of major findings. In contrast to the reports from the laboratory of Gainer et al. (2, 6, 16) , we were unable to confirm enhancement of pulmonary O 2 diffusive transport by TSC in a highly diffusion-limited situation of hypoxic exercise. We did note some minor differences between the control and post-TSC runs, but these were related to 1) changes in V CO 2 and CO 2 transport and 2) changes in V A/Q matching.
Lack of effect of TSC. The lack of effect of TSC in the present study could have several explanations. First, the diffusion-enhancement hypothesis, in vivo, may not be true. In vivo, convective motion of red blood cells in the pulmonary circulation could overcome potential diffusive resistance of the plasma, such that the potential benefit of TSC may not be realized. Second, even if TSC enhances plasma O 2 movement, if that component of O 2 diffusive exchange between alveolar gas and capillary blood is quantitatively minor, TSC may have no measurable effect. Thus, if crossing the alveolarcapillary membrane and/or binding to Hb in the red blood cell offer the major resistances to O 2 exchange, the plasma enhancement may not accelerate the overall exchange process to any measurable degree. Third, the concentration of TSC may have been insufficient to elicit an effect. It appears that TSC disappears rapidly from the plasma (Fig. 5) , but even at this rate about one-half the initial concentration should have still been present at the time of the final measurement during heavy exercise. We used doses similar, per kilogram of body weight, to those used by others (M. Singer, R. P. Stidwell, A. Nathan, and J. L. Gainer, unpublished observations). Figure 4 could be interpreted as providing tantalizing evidence in this direction, since at moderate exercise the post-TSC DL O 2 is numerically greater than the pre-TSC value. Because moderate exercise was always performed sooner after TSC administration than was heavy exercise, the TSC levels must have been higher. Figures 4 and 5 do provide a rationale for repeating these studies at higher doses and, possibly, by continuous infusion to maintain plasma levels. The fourth possible reason for lack of effect of TSC is that O 2 exchange at the lungs was not diffusion limited. This is regarded as extremely unlikely given that the measured A-aPO 2 of ϳ18 Torr exceeded the predicted value at heavy exercise by ϳ13 Torr (Fig. 3) . The only other explanation for the difference under hypoxic conditions between predicted and measured arterial PO 2 would be a postpulmonary shunt through the bronchial or thebesian venous circulation, but a shunt of Ͼ15% of the cardiac output would be required to account for the 13-Torr difference. This is unreasonably high, since such shunts are generally only on the order of 1-2% at most.
Reconciliation with previous work. The only previous reports of crocetin affecting pulmonary gas exchange (2, 6) involve conditions of rest and normoxia, in which alveolar-capillary diffusion limitation is generally not seen, especially in health, but even in diseases (1, 14, 15, 21) . In the study by Holloway and Gainer (10), arterial PO 2 rose progressively over 3 h, whereas cardiac output and iliac (not pulmonary arterial) PO 2 remained constant. Factors not considered by these authors, such as progressive changes in whole body V O 2 or pulmonary V A/Q relationships, might have contributed to the changes in arterial PO 2 . In the emphysematous rats (2), levels of ventilation and/or cardiac output or degrees of V A/Q mismatch may have differed between groups to account for differences in arterial PO 2 ; unfortunately, arterial PCO 2 values were not given. Thus definitive explanations for the differences between previous studies and the present experiment cannot be given, since in the prior work many key variables could not be measured. We did not perform studies during normoxic exercise in these dogs. The basis for this decision was that if TSC does not improve diffusive O 2 exchange during hypoxia, it would not be expected to do so in normoxia, where diffusion limitation is considered to be less evident. However, it remains possible that in normoxia TSC could alter pulmonary gas exchange or that the different conditions in hypoxia could affect the actions of TSC. To that extent, normoxic studies would be useful in resolving the differences between our findings and those of Gainer et al.
Differences in V CO 2 and CO 2 transport between first and second exercise bouts. V CO 2 and the respiratory exchange ratio were systematically lower after than before TSC, and these data were mirrored by independently measured reductions in arterial and mixed venous PCO 2 . Although the effects were physiologically minor (0.1-unit reduction in respiratory exchange ratio, 3-to 4-Torr reduction in PCO 2 ), the question arises as to whether this result was due to TSC. It may have been due to persisting metabolic effects of the prior (control) exercise run without TSC, causing a shift away from carbohydrate toward fat as a substrate for metabolism during the second run (7). It would be necessary to repeat the entire study with two "control" runs to sort this out. Although this was seriously considered, the effort was not believed to be justified given the evident lack of effect of TSC on O 2 transport, which remains the major focus of the study. Prior work from Johnson's laboratory in similar dogs has shown no effect of ordering on cardiopulmonary variables, so the possibility exists that these are TSC-mediated effects. The CO 2 results, however, do point out a limitation of the present study design, since TSC was always studied during the second bout of exercise. The reason for not reversing the order (of giving buffer vs. TSC) was the prolonged duration of effect reported in earlier work, approaching 200 min (10) .
Differences in V A/Q inequality between the first and second exercise bouts. V A/Q matching improved, as shown by the dispersion of the perfusion distribution (Fig. 4) . This was seen at rest and during exercise, and the overall effect was highly significant (P Ͻ 0.001). The quantitative improvement was very small, however, reducing log SD Q by only 0.05 unit from 0.48 to 0.43 (averaged over all conditions). As shown in Fig. 3 , this would have raised arterial PO 2 by just 1 Torr, with all other factors unchanged. As with the above-mentioned effects of TSC on V CO 2 , it is possible that this improvement was due to TSC. However, it is also possible that the prior effects of the first, control exercise runs were in some way responsible for the V A/Q changes independently of TSC. There were no differences in total ventilation or cardiac output pre-vs. post-TSC (Fig. 2) , nor was there a difference in pulmonary artery pressure to explain the V A/Q changes. Domino et al. (3) reported that acidosis improves V A/Q relationships. Because there were no differences, before and after administration of TSC, in arterial (or mixed venous) pH at any exercise level, acidosis cannot account for the small improvement in V A/Q relationships seen in the present study. Again, although no explanation for the reduced log SD Q is apparent, a complete rerun of the protocol without TSC would be required to determine whether a prior bout of exercise or TSC is the explanation. It was believed that this was not justified on the basis of the minor effects on V A/Q matching.
Effect of pneumonectomy/lobectomy on response to TSC. Because lung gas-exchange surface area was reduced after pneumonectomy or lobectomy, it is possible that diffusion of O 2 through plasma may contribute less to total diffusive resistance in pneumonectomized/lobectomized dogs than in normal animals. Figure 6 explores this possibility by presenting arterial PO 2 before and after TSC during heavy exercise in each animal studied. There was no difference in the effects of TSC on arterial PO 2 as a function of surgical state. This further suggests lack of diffusive enhancement of O 2 transport by TSC.
In summary, we have failed to corroborate the several reports of enhanced O 2 transport across the lungs by crocetin, under conditions where diffusion limitation of O 2 exchange could be well demonstrated. This could reflect 1) an insufficient concentration of crocetin at the time of measurement; 2) possible enhancement by crocetin of a part of the O 2 diffusion pathway that contributes minimally to O 2 transport resistance, even in the absence of the compound; or 3) lack of effect of TSC on the diffusion of O 2 through plasma, refuting the basic hypothesis of its mechanism of action.
